专利号:US-2022259202-A1 优先权日:2019-06-17 标题:1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-amine derivatives and related compounds as toll-like receptor (tlr) 7/8 agonists, as well as antibody drug conjugates thereof for use in cancer therapy and diagnosis 发明人:MEIMETIS LABROS 权利人:SUTRO BIOPHARMA INC 摘要:1-(4-(aminomethyl)benzyl)-2-butyl-2H-pyrazolo[3,4-c]quinolin-4-amine derivatives thereof and related compounds of formula (I) as toll-like receptor (TLR) 7/8 agonists for cancer therapy. Linker payload compounds thereof, and antibody conjugates thereof for cancer diagnosis. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 145 to 156; examples 1 to 3; biological examples 1 to 6; tables 1 and 2).
参考文献:10.1016/j.chembiol.2015.06.009 摘要:Lang L, Ding H, Chen X, Sun S, Liu G, Yan C. Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds. Chemistry & Biology. 2015 Jul;22(7):957–64. doi: 10.1016/j.chembiol.2015.06.009.